23 Nov Antonios Douros
Antonios Douros, MD, PhD is an Assistant Professor in the Department of Medicine of McGill University and an Investigator at the Lady Davis Institute of the Jewish General Hospital in Montreal, Quebec. He obtained his MD and PhD from Charité – Universitätsmedizin Berlin in Berlin, Germany, where he also had training in Clinical Pharmacology. He completed his post-doctoral training in Pharmacoepidemiology at the Centre for Clinical Epidemiology at the Lady Davis Institute in Montreal.
Professor Douros started participating in CNODES in November 2018, and he is currently serving as a Liaison for the CPRD site on several studies. In addition to his work with CNODES, Prof. Douros leads an active research program in drug effectiveness and safety in vulnerable populations, including patients with liver disease, older adults, as well as patients subject to polypharmacy and at risk of drug-drug interactions. Professor Douros’s research program is funded by the Canadian Institutes of Health Research, and he is the recipient of a Chercheur-Boursier Junior 1 award from the Fonds de Recherche du Québec – Santé.
Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort studySite Investigator, CPRD
Sodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort studySite Investigator, CPRD
Sodium-glucose cotransporter 2 inhibitors and the risk of below-knee amputation: a multicenter observational studySite Investigator, CPRD
Sodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort studySite Investigator, CPRD
Validity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort studyCollaborator, CPRD
Reviewing the effects of thiazide andthiazide-like diuretics as photosensitizing drugs on the risk of skin cancerProject Co-Lead, Coordinating Center